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A B S T R A C T
The complete nucleotide sequence of a 7.7 kb mobilisable plasmid (pM3446F), isolated from a ﬂorfenicol
resistant isolate of Actinobacillus pleuropneumoniae, showed extended similarity to plasmids found in
other members of the Pasteurellaceae containing the ﬂoR gene as well as replication and mobilisation
genes. Mobilisation into other Pasteurellaceae species conﬁrmed that this plasmid can be transferred
horizontally.
ã2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
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Actinobacillus pleuropneumoniae, one of the main pathogens
contributing to swine respiratory disease throughout the world,
has been used as an indicator organism in surveillance studies of
antimicrobial resistance in bacteria of animal origin (de Jong et al.,
2014; Hendriksen et al., 2008). Tetracyclines, beta-lactams, and
trimethoprim/sulphonamides are the commonest frontline treat-
ments for porcine pleuropnuemonia in Europe (European Med-
icines Agency, 2012), however, levels of resistance are increasing
(de Jong et al., 2014; Vanni et al., 2012). To a lesser extent,
ﬂorfenicol, a ﬂuorinated thiamphenicol derivative licensed to treat
respiratory diseases of pigs and cattle in Europe since 2000 and
1995, respectively (Kehrenberg et al., 2004), has been used. Most
surveys of A. pleuropneumoniae antimicrobial susceptibility have
shown that nearly all isolates are susceptible to ﬂorfenicol, except
in Korea where resistance levels of 34% were recently reported* Corresponding author. Tel.: +44 0 20 759 41803; fax: +44 0 20 759 4398.
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http://dx.doi.org/10.1016/j.vetmic.2015.05.020
0378-1135/ã 2015 The Authors. Published by Elsevier B.V. This is an open access artic(Gutiérrez-Martín et al., 2006; Kucerova et al., 2011; Priebe and
Schwarz, 2003; Shin et al., 2005; Vanni et al., 2012; Yoo et al., 2014).
A chloramphenicol/ﬂorfenicol efﬂux pump, encoded by ﬂoR
(Schwarz et al., 2004), has been detected by PCR in ﬂorfenicol-
resistant A. pleuropneumoniae isolates (Kucerova et al., 2011; Yoo
et al., 2014), and this resistance was transferrable to Escherichia coli
(Yoo et al., 2014), however no plasmid was characterised.
Here we describe the isolation and characterisation of a 7.7 kb
ﬂorfenicol resistance plasmid from a clinical isolate of A. pleuro-
pneumoniae. Comparative sequence analysis of this plasmid with
others reported as mediating ﬂorfenicol resistance in bovine
isolates of Pasteurella multocida (Kehrenberg and Schwarz, 2005;
Kehrenberg et al., 2008) and Mannheimia haemolytica (Katsuda
et al., 2012) is also described.
1.1. Material and methods
1.1.1. Bacterial isolates and MIC measurements
A. pleuropneumoniae MIDG3446, a serovar 2 clinical isolate, was
originally cultured from pneumonic lungs of a pig in Greece in
2010 and archived at the then Animal Health and Veterinary
Laboratory Agency (now Animal and Plant Health Agency) in
England. Minimum inhibitory concentrations (MIC) for ﬂorfenicol
and chloramphenicol were determined by agar dilution using
Chocolate Mueller-Hinton plates, with A. pleuropneumoniae ATCCle under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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ATCC 29213 used as quality control strains (CLSI, 2008).
1.1.2. Plasmid isolation and conﬁrmation of ﬂoR by PCR
Plasmid DNA was isolated using a Qiaprep Spin Miniprep kit
(Qiagen) according to the manufacturer's protocol. The presence of
the ﬂoR gene was conﬁrmed by PCR using primers ﬂoR_for
(CGACGCCCGCTATGATCCAACTC) and ﬂoR_rev (CCCAAAAAGCCG-
GACTCGCGAAG). Initially, ﬂorfenicol resistance was transferred to
E. coli Stellar cells (Clontech) by heat shock with the
MIDG3446 plasmid extract, according to the manufacturer's
protocol, with selection of transformants on LB agar supplemented
with 10 mg/ml ﬂorfenicol. Subsequently, mobilisation into selected
Pasteurellaceae strains was assessed using a mating protocol
previously described (Bossé et al., 2009; Bossé et al., 2015).
Recipient strains included nalidixic acid resistant derivatives of M.
haemolytica (MIDG1579NalR), P. multocida (MIDG1570 NalR), and
Haemophilus parasuis (MIDG3176NalR), as well as the NAD-
independent A. pleuropneumoniae isolate, MIDG2331DureC::nadV,
previously described (Bossé et al., 2009; Bossé et al., 2014).
Transconjugants were selected on Brain Heart Infusion agar (with
or without 0.01% NAD or 20 mg/ml nalidixic acid, as appropriate)
supplemented with 2 mg/ml ﬂorfenicol. Transformants and trans-
conjugants were tested by PCR for the presence of ﬂoR, as above,
and for the nadV gene, as previously described (Bossé et al., 2015),
where appropriate. MICs for ﬂorfenicol and chloramphenicol were
determined, as above, for recipient strains +/ plasmid.
1.2. Plasmid sequence
A plasmid carrying the ﬂoR gene was isolated from a selected E.
coli transformant (above) and the complete nucleotide sequence
was determined using a primer walking strategy. Sequence
analysis was carried out using BLASTn and BLASTx. Alignments
with other ﬂoR plasmids were done using ClustalW. The sequence
of the A. pleuropneumoniae ﬂoR plasmid (pM3446F) has been
deposited to Genbank (accession number KP696484).
2. Results and discussion
A serovar 2 isolate of A. pleuropneumoniae, MIDG3446, was
found to be resistant to ﬂorfenicol and chloramphenicol (Table 1).
Analysis of DNA from MIDG3446 revealed multiple small plasmids,
one of which when transformed into E. coli Stellar cells (Clontech),
conferred resistance to ﬂorfenicol and chloramphenicol (Fig. 1;
Table 1). Additionally, mobilisation from MIDG3446 was successful
into A. pleuropneumoniae MIDG2331DureC::nadV and M. haemo-
lytica MIDG1579NalR, but not P. multocida MIDG1570NalR nor H.
parasuis MIDG3176NalR. The location of the genes encoding the
conjugation machinery was not determined, and no attempts wereTable 1
Antimicrobial susceptibility for strains with and without plasmids.
Strain Species MIC (
Florfe
MIDG3446 Apa 8 
MIDG2331DureC::nadV Ap 2 
MIDG2331DureC::nadV + pM3446F Ap 8 
MIDG1579 Mhb 1 
MIDG1579 + pM3446F Mh 16 
Stellar Ecc 2 
Stellar + pM3446F Ec 16 
a Ap = A. pleuropneumoniae.
b Mh = M. haemolytica.
c Ec = E. coli.made to optimise mating conditions, nor were other isolates of
these species tested. PCR conﬁrmed the presence of ﬂoR in
transformants and transconjugants (Fig.1), and MICs for ﬂorfenicol
and chloramphenicol, determined as above, for recipient strains
+/ plasmid indicated transfer of resistance with the plasmid
(Table 1).
The complete 7,709-bp sequence of pM3446F, isolated from a
selected E. coli transformant, was determined using a primer
walking strategy. Sequence analysis using BLASTn and BLASTx
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) revealed extended simi-
larity to pMh1405 (AB621552), a 7,674-bp plasmid isolated in
2009 from an M. haemolytica strain recovered from a calf in Japan
(Katsuda et al., 2012), and to a lesser extent to pCCK381
(AJ871969), a 10,874-bp plasmid isolated in 2005 from a P.
multocida strain recovered from a calf in Thirsk, England
(Kehrenberg and Schwarz, 2005), and subsequently from bovine
and porcine isolates of P. multocida in Germany (Kehrenberg et al.,
2008). All three Pasteurellaceae-derived plasmids (Fig. 2) have
virtually identical replication (repA-C) and mobilisation genes
(mobA-C), as well as oriV and oriT sequences, as those comprising
pDN1 (Fig. 2), a 5,112-bp RSF1010-like IncQ broad-host-range
plasmid (Y19120) isolated from Dichelobacter nodosus, the causa-
tive agent of ovine footrot (Kehrenberg and Schwarz, 2005;
Rawlings and Tietze, 2001; Whittle et al., 2000). However, whereas
pDN1 does not encode resistance genes, these Pasteurellaceae
plasmids contain differing fragments of what was initially
described as TnﬂoR, a transposable element encoding ﬂoR, a lysR
transcriptional regulator, and the tnpA transposase (Doublet et al.,
2005), and subsequently shown to be an ISCR2-ﬂoR element
(Toleman et al., 2006). Similar sequences have been found in
various plasmids and chromosomes of different bacterial species,
suggesting recombination and/or deletion events following
integration have given rise to different truncated forms of the
genes ﬂanking ﬂoR (Doublet et al., 2005; Schwarz et al., 2004;
Toleman et al., 2006).
The sequences ﬂanking ﬂoR in these Pasteurellaceae plasmids
show greatest similarity to those found in pAQU1 (AB571865), a
200 kb conjugative plasmid isolated from Photobacterium dam-
selae, subsp. damselae in Japan (Nonaka et al., 2012). In Figure 2,
only the sequence around the ISCR2-ﬂoR element of pAQU1 is
shown (from bases 138014 to 143017 in the Genbank annotated
sequence), with the Dtnp gene upstream of ﬂoR almost identical to
the last 720 bases of the tnp gene downstream. In pCCK381, in
addition to the partial ISCR2-ﬂoR (99% identity with pAQU1 bases
138160–141381), the 2062 bases comprising the end of the lysR
gene to the start of the oriV are 99% identical to bases 146509–
148591 of pAQU1. Whereas, upstream of the Dtnp gene in
pCCK381, there are sequences 99-100% identity with other regions
(bases 148616–148778 and bases 148992–149190) of pAQU1. In
pMh1405, the 2.5 kb upstream of oriV shares 99% identity withmg/ml) Source or Reference
nicol Chloramphenicol
8 This study
2 (Bossé et al., 2014)
8 This study
1 (Bossé et al., 2009)
16 This study
4 Clontech
32 This study
Fig. 1. Transfer of ﬂorfenicol resistance plasmid from A. pleuropneumoniae MIDG3446 by transformation into E. coli Stellar, or mating into M. heamolytica MIDG1579 and A.
pleuropneumoniae MIDG2331 DureC::nadV.
(A) Comparison of plasmid extracts from donor strain MIDG3446 (lane 1), recipient strains E. coli Stellar, M. heamolytica MIDG1579 and A. pleuropneumoniae MIDG2331
DureC::nadV (lanes 2-4), and respective ﬂorfenicol resistant transformant/transconjugants showing transfer of plasmid pM3446F into E. coli Stellar, M. heamolytica
MIDG1579, and A. pleuropneumoniae MIDG2331 DureC::nadV (lanes 5-7)
(B) Multiplex PCR ampliﬁcation of ﬂoR (510-bp amplicon) and nadV (1.5 kb amplicon) from A. pleuropneumoniae MIDG3446 (lane 1), E. coli Stellar (lane 2), M. heamolytica
MIDG1579 (lane 3), A. pleuropneumoniae MIDG2331 DureC::nadV (lane 4), E. coli Stellar + pM3446F (lane 5), M. heamolytica MIDG1579 + pM3446F (lane 6), A.
pleuropneumoniae MIDG2331 DureC::nadV + pM3446F (lane 7).
Fig. 2. Schematic comparison of ﬂorfenicol resistance plasmid pM3446F from A. pleuropneumoniae with plasmids pAQU1 (from Photobacterium damselae, subsp. damselae),
pCCK381 and pMH1405 (from related Pasteurellaceae), and pDN1 (from Dichelobacter nodosus). Note: only 5.3 kb (from bases 138014–143017 of 204052 total) of pAQU1 is
shown. Reading frames are indicated by arrows, with arrowheads showing direction of transcription (ﬂoR: ﬂorfenicol resistance; lysR: transcriptional regulator; lysR*: partial
lysR; tnp: transposase; Dtnp: truncated transposase; mob,mobA, mobB, mobC: plasmid mobilisation; repA, repB, repC: plasmid replication). The predicted origins of replication
(oriV; ) and transfer (oriT; ) are shown. Grey blocks between sequences indicate  98% nucleotide sequence identity. A distance scale in kb is shown.
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ISCR2-ﬂoR than that seen in pCCK381); and in pM3446F no tnp
sequences remain (with bases 622–2522 of pM3446F being 99%
identical to bases 139426–141904 of pAQU1). An orf downstream
of ﬂoR in pM3446F shows partial identity with lysR, with the ﬁrst
223/348 bp being 100% identical to bases 141107–141329, and
bases 214–334 of the orf having 98% identity with bases 148514–
148633, of pAQU1. In addition, bases 25– 597 of pM3446F are 99%identical to bases 148616–149190 of pAQU1, parts of which are
conserved in the sequence upstream of the Dtnp gene in pCCK381.
These data suggest that these Pasteurellaceae plasmids share a
common origin, with sequences from pAQU1 (or a related plasmid)
having integrated into pDN1, and subsequent deletions/rearrange-
ments of the inserted sequences.
Two further Pasteurellaceae ﬂoR plasmids have been identiﬁed:
pCCK1900 (NC_011378), a 10,226-bp plasmid from a porcine
282 J.T. Bossé et al. / Veterinary Microbiology 178 (2015) 279–282isolate of P. multocida in Germany (Kehrenberg et al., 2008) that in
encodes resistance to ﬂorfenicol (ﬂoR), sulphonamide (sul2), and
streptomycin (strA, strB); pCCK13698 (NC_007800), a 14,969-bp
plasmid from a bovine isolate of Bibersteinia trehalosi in France
(Kehrenberg et al., 2006) that encodes resistance to ﬂorfenicol
(ﬂoR), chloramphenicol (catA3) and sulphonamide (sul2). The
sequence of pCCK1900 shows simple integration of the ﬂoR and
lysR genes into an RSF1010 backbone (Kehrenberg et al., 2008).
Although pCCK13698 shares some rep and mob gene sequences, as
well as the sul2 gene, with RSF1010, it shows more extensive
rearrangements with sequences from other plasmids including
pHS-rec from H. parasuis (Lancashire et al., 2005) and
pMVSCS1 from Mannheimia varigena (Kehrenberg and Schwarz,
2002), and the ﬂoR and lysR genes from ISCR2-ﬂoR (Kehrenberg
et al., 2006). Both pCCK1900 and pCCK13698 appear to have arisen
separately from the pDN1-like plasmids described above.
3. Conclusion
In summary, to our knowledge, this is the ﬁrst report of a
complete sequence of a mobilisable ﬂorfenicol resistance plasmid
from A. pleuropneumoniae. Structural analysis of pM3446F revealed
extensive similarity to two ﬂorfenicol resistance plasmids found in
other members of the Pasteurellaceae, and mating experiments
conﬁrmed the ability to mobilise between species. This highlights
the importance of continued surveillance of ﬂorfenicol suscepti-
bility in A. pleuropneumoniae and other Gram-negative pathogens
that may co-exist within the respiratory tract of pigs.
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